<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> can result in varying degrees of tissue damage </plain></SENT>
<SENT sid="1" pm="."><plain>Conditions of severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> can produce extensive areas of irreversible injury, whereas in conditions of moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, tissue damage may be reversible, as in the region of the ischemic penumbra </plain></SENT>
<SENT sid="2" pm="."><plain>The reversibility of tissue damage in the penumbral region is of clinical interest, because the characterization of conditions underlying this reversible state may provide information needed for the development of new therapeutic approaches for treatment </plain></SENT>
<SENT sid="3" pm="."><plain>Our previous studies demonstrated neurochemical alterations in the levels of <z:chebi fb="40" ids="18243">dopamine</z:chebi> (<z:mp ids='MP_0000273'>DA</z:mp>) within the striatum after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In the present study, we postulate that these changes may be caused, in part, by alterations in transmitter release and reuptake </plain></SENT>
<SENT sid="5" pm="."><plain>To test this hypothesis, forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced in Sprague-Dawley rats (Harlan, Indianapolis, IN) by means of bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> and hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Cerebral blood flow (CBF) in the striatum was measured by the method of hydrogen clearance, and the extracellular <z:mp ids='MP_0000273'>DA</z:mp> ([<z:mp ids='MP_0000273'>DA</z:mp>]e) levels were measured by in vivo microdialysis </plain></SENT>
<SENT sid="7" pm="."><plain>Varied reductions of CBF were induced and maintained for 5 hours </plain></SENT>
<SENT sid="8" pm="."><plain>Three subgroups were established retrospectively according to the degree of CBF reduction: 67.7, 35.6, and 13.2% of <z:mpath ids='MPATH_458'>normal</z:mpath> CBF in the mild, moderate, and severe ischemic groups, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>The induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> resulted in 1.9-, 9.3-, and 122.3-fold increases in [<z:mp ids='MP_0000273'>DA</z:mp>]e above baseline in the mild, moderate, and severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> groups, respectively </plain></SENT>
<SENT sid="10" pm="."><plain>At 3 hours after the induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, high <z:chebi fb="120" ids="26216">potassium</z:chebi> (100 mmol/L) or <z:chebi fb="0" ids="116225">Nomifensin</z:chebi> (Sigma, St </plain></SENT>
<SENT sid="11" pm="."><plain>Louis, MO) (10 mmol/L), a <z:mp ids='MP_0000273'>DA</z:mp> uptake blocker, was administrated via a microdialysis probe to stimulate <z:mp ids='MP_0000273'>DA</z:mp> release while reductions in CBF were maintained continuously </plain></SENT>
<SENT sid="12" pm="."><plain>Thirteen rats were used in the study of the release of <z:mp ids='MP_0000273'>DA</z:mp> by <z:chebi fb="120" ids="26216">potassium</z:chebi> or <z:chebi fb="0" ids="116225">Nomifensin</z:chebi> in nonischemic conditions </plain></SENT>
<SENT sid="13" pm="."><plain>The administration of high <z:chebi fb="120" ids="26216">potassium</z:chebi> or <z:chebi fb="0" ids="116225">Nomifensin</z:chebi> stimulated <z:mp ids='MP_0000273'>DA</z:mp> release in conditions of mild and moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>The increase in <z:mp ids='MP_0000273'>DA</z:mp> release by <z:chebi fb="120" ids="26216">potassium</z:chebi> stimulation was higher in rats with mild <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (106.6-fold) than that in <z:mpath ids='MPATH_458'>normal</z:mpath> rats (22.3-fold) </plain></SENT>
<SENT sid="15" pm="."><plain>This suggests a hyperexcitability of <z:mp ids='MP_0000273'>DA</z:mp> terminals under mild <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, as compared with nonischemic conditions </plain></SENT>
<SENT sid="16" pm="."><plain>On the other hand, <z:chebi fb="0" ids="116225">Nomifensin</z:chebi> increased [<z:mp ids='MP_0000273'>DA</z:mp>]e levels more in moderately ischemic brains than in control brains, suggesting that <z:mp ids='MP_0000273'>DA</z:mp> uptake is up-regulated in the former case </plain></SENT>
<SENT sid="17" pm="."><plain>The increased release of <z:mp ids='MP_0000273'>DA</z:mp> by <z:chebi fb="120" ids="26216">potassium</z:chebi> and <z:chebi fb="0" ids="116225">Nomifensin</z:chebi> was sustained after stimulation in conditions of mild and moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="18" pm="."><plain>The high level of [<z:mp ids='MP_0000273'>DA</z:mp>]e with severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> after ischemic induction was sustained throughout the period of study and was not stimulated by <z:chebi fb="120" ids="26216">potassium</z:chebi> or <z:chebi fb="0" ids="116225">Nomifensin</z:chebi> </plain></SENT>
<SENT sid="19" pm="."><plain>We conclude that under conditions of mild and moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, <z:mp ids='MP_0000273'>DA</z:mp> terminals become highly excitable and reuptake mechanisms are compromised </plain></SENT>
<SENT sid="20" pm="."><plain>These changes of <z:mp ids='MP_0000273'>DA</z:mp> metabolism during mild and moderate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> may explain the sustainability of neurons in the "penumbra" condition of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and the transformation of the ischemic penumbra to a necrotic core </plain></SENT>
</text></document>